iifl-logo

Beta Drugs Ltd Share Price Live

Add as a Preferred Source on Google
₹2,585
(-3.12%)
Aug 12, 2026|11:54:58 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹2,721
  • Day's High₹2,807.9
  • 52 Wk High₹2,712
  • Prev. Close₹2,668.3
  • Day's Low₹2,550.1
  • 52 Wk Low ₹990.1
  • Turnover (lac)2,358.03
  • P/E184.53
  • Face Value₹10
  • Book Value₹141.85
  • EPS14.46
  • Mkt. Cap (Cr.)₹2,865.7
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Beta Drugs Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹2,721

Prev. Close

₹2,668.3

Turnover(Lac.)

₹2,358.03

Day's High

₹2,807.9

Day's Low

₹2,550.1

52 Week's High

₹2,712

52 Week's Low

₹990.1

Book Value

₹141.85

Face Value

₹10

Mkt Cap (₹ Cr.)

2,865.7

P/E

184.53

EPS

14.46

Divi. Yield

0

Beta Drugs Ltd Corporate Action

3 Sep 2025

12:00 AM

AGM

Announcement Date: 03 Sep, 2025

arrow

21 Mar 2025

12:00 AM

Bonus

arrow

3 Sep 2025

12:00 AM

BookCloser

arrow

15 Jul 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

12 Jan 2026

12:00 AM

EGM

arrow

Beta Drugs Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Beta Drugs Ltd SHAREHOLDING SNAPSHOT

12 Aug, 2026|03:19 PM
Jun-2026May-2026Mar-2026Dec-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 59.09%

Foreign: 0.00%

Indian: 59.09%

Non-Promoter- 7.25%

Institutions: 7.25%

Non-Institutions: 33.64%

Custodian: 0.00%

Read More
Share PriceShare Price

Beta Drugs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

10.09

9.61

9.61

9.61

Preference Capital

0

0

0

0

Reserves

118.94

106.4

86.64

67.85

Net Worth

129.03

116.01

96.25

77.46

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

79.45

58.04

50.56

yoy growth (%)

14.79

21.4

Raw materials

-43.44

-30.44

-27.18

As % of sales

54.68

52.44

53.75

Employee costs

-6.05

-3.41

-1.88

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

9.88

7.46

6.83

Depreciation

-5.26

-2.57

-2.42

-1.85

Tax paid

-2.9

0.24

-0.07

Working capital

6.55

5.39

-7.9

17.2

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

14.79

21.4

Op profit growth

8.99

29.86

EBIT growth

4.45

29.28

Net profit growth

14.05

58.42

View Ratios
Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

384.83

362.36

295.71

227.11

183.84

Excise Duty

0

0

0

0

0

Net Sales

384.83

362.36

295.71

227.11

183.84

Other Operating Income

0

0

0

0

0

Other Income

11.18

6.44

1.36

0.75

0.76

Beta Drugs Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,942

146.194,65,470.981,115.140.825,641.3193.23

Divis Laboratories Ltd

DIVISLAB

8,578.5

75.652,26,630.538910.352,974629.49

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,886

90.281,85,157.374920.694,073222.76

Cipla Ltd

CIPLA

1,463

36.021,18,106.99862.160.894,672.12423.36

Zydus Lifesciences Ltd

ZYDUSLIFE

1,191

31.891,17,705.45339.60.092,723.5237.3

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Beta Drugs Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Rahul Batra

Joint Managing Director

Varun Batra

Whole-time Director

Balwant Singh

Whole-time Director

Ashutosh Shukla

Non Executive Director

Ajay Mahipal

Independent Director

Rohit Parti

Independent Director

Manmohan Khanna

Independent Director

Sanjay Sehgal

Independent Director

Lalit Kumar Watts

Independent Director

Monica Jain

Company Sec. & Compli. Officer

Rajni Brar

Registered Office

Village Nandpur,

Himachal Pradesh - 174101

Tel: 91-1795-236196

Website: http://www.betadrugslimited.com

Email: info@betadrugslimited.com

Registrar Office

C-101 247 Park,

L B S Marg, Vikhroli West,

Mumbai-400083

Tel: 91-22-49186000

Website: https://in.mpms.mufg.com

Email: rnt.helpdesk@in.mpms.mufg.com

Summary

Beta Drugs Limited was incorporated as a private limited company with the name Beta Drugs Private limited at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to publi...
Read More

Reports by Beta Drugs Ltd

Company FAQs

The Beta Drugs Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹2585 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Beta Drugs Ltd is ₹2865.70 Cr. as of 12 Aug ‘26
The PE and PB ratios of Beta Drugs Ltd is 184.53 and 19.65 as of 12 Aug ‘26
The 52-week high/low is the highest and lowest price at which a Beta Drugs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Beta Drugs Ltd is ₹990.1 and ₹2712 as of 12 Aug ‘26
Beta Drugs Ltd's CAGR for 5 Years at 51.58%, 3 Years at 51.29%, 1 Year at 48.54%, 6 Month at 97.14%, 3 Month at 98.86% and 1 Month at 13.65%.
The shareholding pattern of Beta Drugs Ltd is as follows:
Promoters - 59.10 %
Institutions - 7.26 %
Public - 33.65 %

QUICKLINKS FOR Beta Drugs Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.